Business
Helix BioPharma Corp. Announces Fiscal 2009 Results
Helix BioPharma Corp. Announces Fiscal 2009 Results
About this update from Helix Biopharma Corp.
[{"type":"text","content":"\n\n\n\nOct. 29, 2009 (Canada NewsWire Group) -- AURORA, Ontario, Oct. 29 /CNW/ -- Consolidated Statements of Operations(thousand $, except for per share data) 2009 2008 2007---- ---- ----Revenue:Product revenue 3,244 2,952 2,764License fees & royalties 597 639 512Research and development contracts - - 148-- -- ---3,841 3,591 3,424 Expenses:Cost of sales 1,516 1,239 1,139Research and development 10,322 5,064 4,116Operating, general and admin 3,917 3,948 3,570Sales and marketing 969 809 848Amortization of intangibles 12 16 159Amortization of capital assets 274 254 287Stock-based compensation 1,023 44 47Interest income (339) (645) (496)Foreign exchange loss (gain) 133 (327) (9)Impairment of intangibles 98 - 1,332-- - -----17,925 10,402 10,993 Loss before income taxes (14,084) (6,811) (7,569) Income taxes 18 153 105-- --- --- Loss for the year (14,102) (6,964) (7,674)======= ====== ====== Loss per share:Basic (0.27) (0.16) (0.22)Diluted (0.27) (0.16) (0.22) Consolidated Statements of Cash Flows (thousand $) 2009 2008 2007---- ---- ----Cash provided by (used in): Loss for the year (14,102) (6,964) (7,674) Items not involving cash:Amortization of capitalassets 274 254 287Amortization of intangibles 12 16 159Deferred lease credit 123 - -Stock-based compensation 1,023 44 47Impairment of intangibles 98 - 1,332Foreign exchange loss (gain) 133 (327) (9)--- ---- --(12,439) (6,977) (5,858)Change in non-cash workingcapital (718) (20) (221)---- --- ----Operating activities (13,157) (6,997) (6,079) Financing activities 9,659 14,614 6,480Investing activities (932) (266) 6,577Effect of exchange ratechanges on cash and cashequivalents (133) 327 9---- --- - Cash and cash equivalents:Increase/(decrease) inthe year (4,563) 7,678 6,987Beginning of the year 19,057 11,379 4,392------ ------ -----End of the year 14,494 19,057 11,379====== ====== ====== Consolidated Balance Sheet (thousand $) 2009 2008---- ----Current assets:Cash and cash equivalents 14,494 19,057Accounts receivable 1,053 349Inventory 858 458Prepaid and other 1,049 446----- ---17,454 20,310Non current assets 1,865 1,356----- -----Total assets 19,319 21,666====== ====== Current liabilities:Accounts payable & accruals 1,299 598Accrued liabilities 834 546Deferred lease credit 25 --- --2,158 1,144Non current liabilities 98 --- --Total liabilities 2,256 1,144Shareholders' equity 17,063 20,522...